Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MACROmol

MACROmol
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a polymeric platform intended to treat tuberculosis. The company's polymeric platform offers a multi-medicine system for nanomedicine innovation to maximize the clinical impact of therapeutics, enabling patients to have fewer drug regimens with improved results.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Primary Office
  • Cambridge
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MACROmol’s full profile, request a free trial.

MACROmol Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Apr-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

MACROmol Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Accelerate Cambridge Accelerator/Incubator 000 0000 000000 0